SVASINOVAC BIOTECH LTD同业对比
SINOVAC BIOTECH LTD 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SVA本股 | — | — | — | — | 6.8%#2 | -589.1%#8 | -127.0%#4 | -4.5%#3 | -11.0%#3 | 3#3 | — | — |
| SMMT | $13.9B#4 | — | 22.1x#3 | — | — | -387.8%#7 | — | -171.4%#5 | — | — | -9.4%#2 | — |
| SMNR | — | — | — | — | — | -3320.4%#9 | — | — | — | — | — | — |
| SMNRW | — | — | — | — | — | -3320.4%#9 | — | — | — | — | — | — |
| SNY | $51.8B#1 | — | — | — | — | — | — | — | — | — | -11.0%#3 | — |
| SPRC | $2M#7 | — | — | 1.3x#1 | -54.6%#6 | -22.7%#4 | -560.2%#5 | — | — | — | -88.3%#5 | — |
| SXTC | $2M#6 | — | 0.1x#1 | 2.0x#2 | -34.6%#5 | -87.8%#5 | -625.9%#6 | -20.9%#4 | -281.4%#4 | — | -100.0%#6 | — |
| TAK | $29.4B#3 | — | — | — | — | — | — | — | — | — | 25.8%#1 | — |
| TEVA | $45.5B#2 | 65.0x#1 | 5.9x#2 | 2.6x#3 | 4.3%#3 | 186.0%#1 | 12.5%#1 | 18.2%#1 | 5.8%#1 | 7#1 | — | — |
| TEVJF | — | — | — | — | 4.3%#3 | 186.0%#1 | 12.5%#1 | 18.2%#1 | 5.8%#1 | 7#1 | — | — |
| TLPPF | — | — | — | — | 55.6%#1 | -121.2%#6 | 3.7%#3 | — | — | — | — | — |
| TLSA | $113M#5 | — | — | — | — | 32.9%#3 | — | — | — | — | -48.1%#4 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议